Literature DB >> 11702870

Surgical seeding of chordomas.

K I Arnautović1, O Al-Mefty.   

Abstract

OBJECT: Chordomas have a high propensity for local recurrence and progression, as well as for systemic and cerebrospinal fluid metastasis. The authors identified and analyzed a series of patients with chordomas, focusing on an underrecognized pathological entity-surgical seeding of tumor cells.
METHODS: In a retrospective analysis of 82 patients with chordomas treated over a 10-year period (1990-2000), the authors found six patients (7.3%) in whom surgical seeding had occurred. In five (83%) of these patients the primary tumor was located at the clivus. In one (17%), the tumor was present at the cervical spine. There were two male (33%) and four female patients (67%) whose mean age was 34 years. The seeding sites, which were separate from the primary tumor, were located along the operative route or in the abdomen where fat was removed. The seeding was diagnosed 5 to 15 months (mean 12 months) after surgery. One seeding site was present in five patients, and 17 seeding sites were present in one patient. The involved tissues included mucosa, bone, dura, muscle, and fat. After resection, all seedings were confirmed histologically.
CONCLUSIONS: Seeding of chordomas occurs along the operative route and at distant locations where tissue is harvested. Early diagnosis and aggressive surgery are recommended. Based on the results of this study, the authors suggest that surgical techniques, postoperative radiotherapy, neuroradiological follow-up protocol, and even research on chordomas should be reevaluated.

Entities:  

Mesh:

Year:  2001        PMID: 11702870     DOI: 10.3171/jns.2001.95.5.0798

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  16 in total

Review 1.  Comprehensive review on rhino-neurosurgery.

Authors:  Werner Hosemann; Henry W S Schroeder
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

Review 2.  Current therapeutic options and novel molecular markers in skull base chordomas.

Authors:  Filippo Gagliardi; Nicola Boari; Paola Riva; Pietro Mortini
Journal:  Neurosurg Rev       Date:  2011-10-18       Impact factor: 3.042

Review 3.  Infantile clivus chordoma without clivus involvement: case report and review of the literature.

Authors:  D Kombogiorgas; E J St George; S Chapman; M English; G A Solanki
Journal:  Childs Nerv Syst       Date:  2006-03-25       Impact factor: 1.475

4.  Endoscopic transnasal surgery of clival lesions: our experience.

Authors:  Daniele Marchioni; Angelo Musumeci; Cristoforo Fabbris; Stefano De Rossi; Davide Soloperto
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-08       Impact factor: 2.503

5.  Prognostic factors for long-term outcome of patients with surgical resection of skull base chordomas-106 cases review in one institution.

Authors:  Zhen Wu; Junting Zhang; Liwei Zhang; Guijun Jia; Jie Tang; Liang Wang; Zhongcheng Wang
Journal:  Neurosurg Rev       Date:  2010-07-29       Impact factor: 3.042

6.  En bloc resection of a C4 chordoma: surgical technique.

Authors:  Yoseph Leitner; Shay Shabat; Luca Boriani; Stefano Boriani
Journal:  Eur Spine J       Date:  2007-08-23       Impact factor: 3.134

7.  Paraspinal chordoma mimicking a neurofibroma: a rare but important radiological pitfall.

Authors:  Nikhil Kotnis; John Goepel
Journal:  Skeletal Radiol       Date:  2012-11-15       Impact factor: 2.199

8.  Tumour seeding in the surgical pathway after resection of skull base chordoma.

Authors:  Marco Krengli; Arturo Poletti; Eleonora Ferrara; Piero Fossati
Journal:  Rep Pract Oncol Radiother       Date:  2016-03-21

9.  Endoscopic Endonasal Surgery of Clival Chordomas: Preliminary Results.

Authors:  Davide Soloperto; Cristoforo Fabbris; Stefano De Rossi; Angelo Musumeci; Daniele Marchioni
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-04-24

10.  Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer.

Authors:  Sagar R Shah; Justin M David; Nathaniel D Tippens; Ahmed Mohyeldin; Juan C Martinez-Gutierrez; Sara Ganaha; Paula Schiapparelli; Duane H Hamilton; Claudia Palena; Andre Levchenko; Alfredo Quiñones-Hinojosa
Journal:  Cell Rep       Date:  2017-10-10       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.